Depression in nonalcoholic fatty liver disease and all‐cause/cause‐specific mortality
Donghee Kim(Chungnam National University), Aijaz Ahmed(Stanford University), Richie Manikat(Stanford University), George Cholankeril(Baylor College of Medicine), Anjiya Shaikh(University of Connecticut)
Cited by 16
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Nonobese Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2016|346
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
|World Journal of Hepatology|2017|183
Current epidemiology of chronic liver disease
|Gastroenterology report|2023|56
Nonalcoholic fatty liver disease and non-liver comorbidities
|Clinical and Molecular Hepatology|2023|37